NTRALUMINAL suture occlusion, first described by Koizumi and colleagues, 21 has been widely used (with some modifications) to produce focal cerebral ischemia in the rat. Murine models in which intraluminal occluding sutures are placed to establish transient focal cerebral ischemia are also increasingly used. This model has advantages because it can induce ischemia in mice produced by transgenic or gene-targeting technologies. 13 This model is simple in procedure and yet it enables both occlusion and recanalization of the MCA without craniectomy. On the other hand, it has been reported that the shape of the suture occluder and the nature of its nylon monofilament may seriously affect the size of the infarct. 22, 23 The suture occluder blocks not only the orifice of the MCA, but also the orifices of the ACA and the ICA. Spontaneous hyperthermia due to hypothalamic injury and inadvertent premature reperfusion have also been reported in this model. 4, 8, 33, 40 Unlike the vasculature of the human brain, in the rodent blood flow in the PCA is mainly supplied by the ICA. Accordingly, it is possible that the suture occluder could also reduce blood flow in the PCA territory. 20 In this situation, the patency of the PCoA may affect infarct size because this artery supplies blood flow from the SCA to the PCA in rodents. Differences in the genetic backgrounds of mutant animals also affect the patency of the PCoA, 2,39 as seen in the difference between MCA development in C57Black6 and SV129 mice. 27 Because measurement of infarct size in the majority of murine models of focal cerebral ischemia is performed 24 hours after the MCAO, there is the possibility of later infarct evolution, although only a few such reports have appeared in the literature.
the PCoA; and 3) if animals in this model would survive longer than those in intraluminal suture stroke models.
Materials and Methods

Animal Preparation
Ninety-five animals were used and 77 of these were successfully treated in this study. Adult male C57Black6 mice, ranging in age from 9 to 14 weeks, were obtained from Charles River Japan (Yokohama, Japan) and maintained in animal quarters with a standard 12-hour light/dark cycle. The animals were given free access to food and water. All procedures were performed in strict accordance with the US National Institutes of Health Guidelines for the Care and Use of Laboratory Animals (Publication No. 80-23, revised 1996) and were approved by the local Animal Care and Use Committee at the University of Tokyo.
The MCAO Procedure
The mice were initially anesthetized with 4% halothane in a 30% O 2 /70% N 2 O gas mixture for 30 to 60 seconds. Anesthesia was maintained by delivery of 0.8 to 1.5% halothane during surgery via a facemask. The animals were placed on their sides and a 1-cm skin incision was created between the left margin of the orbit and the tragus. Next, the temporalis muscle was incised and the zygomatic process was removed using a dental drill. This procedure enabled retraction of the temporalis muscle anteroinferiorly to expose the foramen ovale (Fig. 1A) . Using the dental drill, a small craniectomy was made above the proximal segment of the MCA, which could be seen through the exposure in the skull. Care was taken to preserve the retroglenoid vein-the main draining vein of the intracranial circulation-as recommended in previous publications. 3 The dura mater was opened with the aid of a 30-gauge needle to expose and occlude the MCA (Fig. 1B) . The MCA segment just proximal to the olfactory branch, which is constantly present, was then either transected with microscissors following electrocauterization to produce permanent occlusion or occluded with a miniature clip (Sundt AVM [arteriovenous malformation] clip No. 1; Johnson & Johnson Professional, Inc., Raynham, MA) to produce transient occlusion. In the latter case, the clip was removed to permit reperfusion either 1 or 2 hours after occlusion. Recanalization was visually confirmed. A single dose of an antibiotic agent (Amycacin, 2.5 mg/kg, Gibco BRL, Grand Island, NY) was applied topically. A 0.5-ml volume of warmed physiological saline was injected subdermally at the back of the animals' necks just after surgery to prevent dehydration. Animals subjected to the same surgery without vessel occlusion served as sham-operated controls. The mice were kept in temperature-controlled cubicles (34˚C) for 24 hours after surgery to prevent hypothermia and were allowed free access to food and water. The day of surgery was defined as Day 0.
Experimental Paradigm
There were three categories of experiment. Experiment 1 constituted the acute phase study. Twenty-four of 30 mice were successfully treated. These animals were killed 24 hours following MCAO, after which we determined the infarct volume and assessed the patency of the PCoA. Experiment 2 constituted the subacute phase study. Twenty-four of 32 mice were successfully treated. These animals were killed 7 days following MCAO, after which we determined the infarct volume and assessed the patency of the PCoA. Neurological examination was performed and survival rates were calculated in this experiment. 35 In addition, sham surgery was also performed to assess effects on body weight and survival. Ten mice were successfully treated, but two died during the timepoint examined. In Experiment 3, lCBF was measured during ischemia and 1 hour after reperfusion by performing LDF. Eighteen mice were used in this experiment. Three animals died during the procedure. In addition to these experiments, in five animals a histopathological examination was made of arteries that had been temporarily occluded by miniature clips.
Physiological Variables
The right femoral arteries of the animals in Experiment 1 were cannulated using a polyethylene catheter (PE-10; Clay Adams, Parsippany, NJ) for blood pressure monitoring and serial blood gas sampling. This procedure was avoided in the animals in Experiment 2, because they would have suffered from hindlimb paresis on the cannulated side and would not have been suitable for survival experiments. Except for the cannulation the procedure followed the same protocol as Experiment 1. Mean arterial blood pressure was monitored using a transducer amplifier (Nihon Koden, Tokyo, Japan), and PaO 2 , PaCO 2 , and pH were measured with the aid of pH and blood gas analyzer (model 248; Corning Medical, Medfield, MA). Temperatures in the rectal and temporalis muscles were measured in Experiments 1 and 2 and were maintained at 37 Ϯ 0.5˚C by using an animal blanket controller (model ATB-1100; Nihon Koden) during all surgical procedures and during recovery from anesthesia (that is, until normal locomotor activity had been observed). The exact timing of systemic measurement was just before MCAO, during MCAO (30 minutes after initiation of MCAO in the 1-hour MCAO group and 1 hour after initiation of MCAO in the 2-hour MCAO group), and 15 minutes after recanalization (Table 1) . Body weight was monitored at 24 hours and at 4 and 7 days after MCAO in Experiment 2. Each animal's body weight before surgery was defined as FIG. 1. Intraoperative photographs obtained during surgery to produce a proximal MCAO. A: The temporalis muscle has been incised, followed by removal of the zygomatic process. Here the temporalis muscle is retracted anteroinferiorly to expose the foramen ovale and the trigeminal nerve (arrowheads). B: The proximal segment of the MCA is visualized after a small craniectomy. The dura mater has been opened. The olfactory branch originating from the proximal segment of the MCA is present (arrows).
100%, and subsequent daily weights were expressed relative to this value.
Assessment of the Infarct
Twenty-four hours after MCAO in Experiment 1 and 7 days after MCAO in Experiment 2, the mice were deeply anesthetized with 4% halothane (in 30% O 2 /70% N 2 O) and were perfused with 50 ml of heparinized phosphate-buffered saline (10 U/ml, pH 7.4) followed immediately by 50 ml of 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.43). Their brains were left in situ overnight and then cryoprotected by transfer to a solution containing between 10 and 30% (w/v) sucrose gradient in phosphate-buffered saline at 4˚C. The brain samples were randomly numbered to blind the researcher to the experimental subgroup (that is, 1-hour, 2-hour, and permanent MCAO). The brains were then cut into 20-m sections, 500 m apart, at 12 predetermined coronal levels (between 2.1 mm anterior and Ϫ 3.4 mm posterior to the bregma) 30 on a cryostat (Jung Frigocut, model 2800 E; Leica, Nussloch, Germany) at Ϫ20˚C. The sections were stained with cresyl violet. Infarct sizes were determined using a digitized imaging system (Scion Image, version 1.62; Scion Corp., Frederick, MD). The volumes were calculated by integration of sequential areas. The volumes of ischemic injuries were corrected for brain swelling by using two different formulas derived from those posited by Leach (Swanson correction) . The Leach correction was calculated as follows: (contralateral hemisphere area/ipsilateral hemisphere area) ϫ ipsilateral lesion area. The Swanson correction for expressing lesion volume as a percentage of the whole hemisphere was calculated using the following formula: 100 ϫ (contralateral hemisphere volume Ϫ nonlesioned ipsilateral hemisphere volume)/contralateral hemisphere volume.
Local CBF Measurement
In a separate set of animals lCBF was monitored in the ischemic core (1 mm anterior and 5 mm lateral to the bregma) during ischemia and at 1 hour after reperfusion by performing LDF (ALF21 [Advance Laser Flowmeter 21]; Advance Co., Ltd., Tokyo, Japan) to assess the degree of ischemia and reperfusion (five animals in each group). The head of each animal was fixed in a stereotactic frame (Stoelting Co., Wood Dale, IL) and the animal was placed on its side. The LDF probe was secured perpendicular to the skull surface by using a holding device. Ten readings (2 seconds apart) of lCBF were collected from the digital display of the LDF unit and were averaged to provide an lCBF value for each location. The initial lCBF reading was recorded as 100% and subsequent flow changes were expressed relative to this value. Permanent MCAO and transient MCAO were induced in the same manner as described earlier.
Neurological Examination
The neurological score for each animal was determined according to a standardized method published previously.
14 In Experiment 2, neurological examinations were performed at 24 hours and at 4 and 7 days after occlusion (just before the mice were killed). The score was graded as follows: 0, normal motor function; 1, flexion of contralateral torso and forelimb when the whole animal is lifted by the tail; 2, circling to the contralateral side during movement, but normal posture at rest; 3, leaning to the contralateral side at rest; and 4, no spontaneous motor activity.
Evaluation of the PCoA on the Ischemic Side
Following transcardial perfusion fixation, which took place 24 hours after MCAO in Experiment 1 and 7 days after MCAO in Experiment 2, 0.2 ml of carbon black in an equal volume of 20% gelatin in H 2 O was injected into the animals. In both 1-and 2-hour MCAO groups, any brain specimens in which the MCA trunks did not fill with carbon black solution were not used for further evaluation because occlusion was permanent rather than transient. An investigator blinded to the experimental subgroups evaluated the degree of the patency of the ipsilateral PCoA by using a microscope and applying the following scoring system: 0, no anastomosis between the PCA and the SCA; 1, anastomosis between the PCA and SCA in the capillary phase; 2, small truncal PCoA; and 3, truncal PCoA. 28 
Statistical Analysis
A parametric one-way ANOVA or the Student t-test was used to compare the physiological parameters and to assess infarct size. A two-way ANOVA was used to evaluate changes in body weight and assignment of serial neurological scores permitted correlations to be made between the experimental subgroups and the time course. Post hoc comparisons were made by performing the Fisher PLSD test after the multivariate tests. The Pearson correlation coefficient was used to analyze the correlation between infarct size and the patency of the PCoA. Differences were considered to be significant at a probability value less than 0.05.
Results
Physiological Variables
In Experiment 1, intraischemic (during MCAO) physiological variables were assessed 30 minutes after initiation of occlusion in the 1-hour MCAO group and 1 hour after initiation of occlusion in the 2-hour MCAO group. Before occlusion the PaCO 2 of the 1-hour MCAO group was significantly lower than that of the 2-hour MCAO group (p Ͻ 0.05, one-way ANOVA; Table 1 ). There were no other significant differences in the physiological variables that we measured.
Success Rate
The numbers of successfully treated animals in each subgroup in Experiments 1 and 2 were as follows: permanent MCAO group, eight of 11 animals in both Experiments 1 J. Neurosurg. / Volume 100 / January, 2004 † Significantly lower than variable in 2-hour MCAO group (p Ͻ 0.05, one-way ANOVA). and 2; 1-hour MCAO group, eight of nine animals in Experiment 1 and eight of 11 animals in Experiment 2; and 2-hour MCAO group, eight of 10 animals in both Experiments 1 and 2. In the sham-operated group, eight of 10 animals survived until 7 days after surgery.
Daily Changes in Body Weight
The animals lost weight during the 7 days after surgery. The percentages of baseline weight at 24 hours after MCAO were as follows: 90.4 Ϯ 3.8% in the sham-operated group, 90.7 Ϯ 1.9% in the 1-hour MCAO group, 88.2 Ϯ 1.4% in the 2-hour MCAO group, and 90 Ϯ 2.9% in the permanent MCAO group. At Day 4, these percentages were 91 Ϯ 6.3% in the sham-operated group, 89.4 Ϯ 6.6% in the 1-hour MCAO group, 82.3 Ϯ 6.1% in the 2-hour MCAO group, and 83.9 Ϯ 9.1% in the permanent MCAO group. At Day 7, the weight percentages reached 92.5 Ϯ 6.5% in the sham-operated group, 90.6 Ϯ 6.9% in the 1-hour MCAO group, 80.1 Ϯ 10.9% in the 2-hour MCAO group, and 80.8 Ϯ 11% in the permanent MCAO group. The percentages of baseline weight in the sham-operated and 1-hour MCAO groups were significantly higher than those in the 2-hour and permanent MCAO groups (two-way ANOVA followed by the Fisher PLSD test, p Ͻ 0.05, respectively) (Fig. 2) . Nevertheless, there was no significant difference in percentages of body weight loss between the sham-operated and 1-hour MCAO groups on the one hand and the 2-hour and permanent MCAO groups on the other hand.
The percentages of baseline weight assessed at 24 hours were significantly higher than those determined at Day 7 (two-way ANOVA followed by the Fisher PLSD test, p Ͻ 0.05). The interaction of group (duration of ischemia) with time was not significant. FIG. 2. Graph demonstrating changes in body weights monitored at baseline, 24 hours, 4 days, and 7 days after MCAO (eight animals in each group). The percentages of the baseline weight in the shamoperated (diamonds) and 1-hour MCAO (squares) groups were significantly higher than those in the 2-hour (triangles) and permanent (circles) MCAO groups (two-way ANOVA followed by the Fisher PLSD test, *p Ͻ 0.05). There was no significant difference between the sham-operated and 1-hour MCAO groups. Differences over time (a comparison of 24 hours, 4 days, and 7 days) were also significant. The percentages of baseline weights measured at 24 hours were significantly higher than those measured on Day 7 in each group (p Ͻ 0.05). 
Infarct Size
There were no significant intergroup differences in body weight and hemisphere volumes between Experiments 1 and 2 ( Table 2 ). Figure 3 shows the site at which the MCA was occluded as well as histopathological findings. In Experiment 1, the infarct volumes in the 1-hour, 2-hour, and permanent MCAO groups were as follows: (Fig. 4A ). The percentages of infarction, calculated using the Swanson formula were 24.3 Ϯ 8.5% in the 1-hour MCAO group, 33.9 Ϯ 7.4% in the 2-hour MCAO group, and 39.2 Ϯ 9.2% in the permanent MCAO group (Fig. 4B ). When measured using both methods, infarct sizes in the 1-hour MCAO group were significantly smaller than those in the 2-hour and permanent MCAO groups (one-way ANOVA followed by the Fisher PLSD test, p Ͻ 0.05 and p Ͻ 0.005, respectively). On the other hand, there was no significant difference in infarct volumes between the 2-hour and permanent MCAO groups in this model. In Experiment 2, the infarct volumes were 11.9 Ϯ 3.5 mm 3 in the 1-hour MCAO group, 17 Ϯ 3.4 mm 3 in the 2-hour MCAO group, and 19.3 Ϯ 4.1 mm 3 in the permanent MCAO group. The percentages of infarction were 21.8 Ϯ 5.1% in the 1-hour MCAO group, 28 Ϯ 6.8% in the 2-hour MCAO group, and 33.6 Ϯ 5.8% in the permanent MCAO group. Using the Leach correction infarct sizes measured in the 1-hour MCAO group were significantly smaller than those in the 2-hour and permanent MCAO groups (one-way ANOVA followed by the Fisher PLSD test, p Ͻ 0.05 and p Ͻ 0.001, respectively; Fig. 4C ). Nevertheless, using the Swanson correction the percentages of infarction in the 1-and 2-hour MCAO groups were significantly smaller than those in the permanent MCAO group (one-way ANOVA followed by the Fisher PLSD test, p Ͻ 0.0005 and p Ͻ 0.01, respectively; Fig. 4D ). There was no significant difference between the 1-and 2-hour MCAO groups with respect to the percentage of infarction.
Neurological Score
The neurological scores examined 24 hours after MCAO in Experiment 2 were 1.5 Ϯ 0. group, 1.9 Ϯ 1 in the 2-hour MCAO group, and 2.4 Ϯ 0.7 in the permanent MCAO group. The scores on Day 4 were 1.6 Ϯ 0.7 in the 1-hour MCAO group, 1.8 Ϯ 0.7 in the 2-hour MCAO group, and 2.1 Ϯ 0.6 in the permanent MCAO group. The final scores on Day 7 before the animals were killed were 1.4 Ϯ 0.7 in the 1-hour MCAO group, 1.8 Ϯ 0.7 in the 2-hour MCAO group, and 1.9 Ϯ 0.6 in the permanent MCAO group. The degree of neurological deficits in the 1-hour and 2-hour MCAO groups was significantly less severe than that in the permanent MCAO group (two-way ANOVA followed by the Fisher PLSD test, p Ͻ 0.005 and p Ͻ 0.01, respectively) (Fig. 5) . Nevertheless, the interaction of group (duration of ischemia) with time was not significant. Differences over time (a comparison of 24 hours, 4 days, and 7 days) were also not significant.
Local CBF Measured by LDF
Local CBF in the ischemic core averaged 30% of the baseline value in the transient MCAO group during ischemia. In contrast, lCBF averaged 20% in the permanent MCAO group. In the transient MCAO group, lCBF recovered an average of 70% relative to the initial value. In the 1-hour MCAO group, lCBF gradually recovered an average of 90% compared with the initial value by 30 minutes after reperfusion. In the 2-hour MCAO group no changes in lCBF were evident over the timepoints examined (Fig. 6) .
Correlation Between Infarct Volumes and the Patency of the PCoA
The grade of the PCoA, that is, its patency, did not differ among the study groups. There was no correlation between infarct volume and the grade of the PCoA (Fig. 7) . The linear regression equations and the Pearson correlation coefficients for the study subgroups at various timepoints are listed in Fig. 7 .
Animal Survival
Survival rates were calculated using the Kaplan-Meier method. In the sham-operated group, two of 10 animals died within 7 days; one died on Day 3 and the other died on Day 4. In the 1-hour MCAO group, three of 11 animals died within 7 days, two died within 24 hours and one died on Day 6. In the 2-hour MCAO group, two of 10 animals died within 24 hours. In the permanent MCAO group, three of 11 animals died within 24 hours. There were no significant intergroup differences with respect to survival rate (Fig. 8) .
Discussion
In this study, we produced focal cerebral ischemia in C57Black6 mice by producing proximal MCAO, which enabled us to achieve substantial consistency in the resulting infarct size (independent of the PCoA) and a high long-term survival rate. Removal of the zygomatic processes has not been performed to create permanent MCAO by others; 19 however, it is necessary to obtain an adequate surgical field for clip application to produce transient MCAO in this model. In fact, the animals did not suffer any difficulties in food intake.
Mouse mutants derived from a targeted mutagenesis in embryonic stem cells offer many advantages for studying molecular and cellular mechanisms. Embryonic stem cells were derived from SV129 mice, but the chimeric mice were bred with mice from a different strain, for example, C57Black6. 9 Accordingly, C57Black6 and S1V129 mice are commonly used as genetic backgrounds for mutants. 35 The C57Black6 mice are suitable for use in models of focal and global cerebral ischemia because of their large MCA territory, 27 robust vasodilatory response, 7 and high susceptibility to ischemia. 39 In intraluminal suture stroke models, the external CA, 25 the common CA, 21 and the ICA 29 are available as possible insertion routes for the suture occluder. When the latter two routes are used, ipsilateral cerebral perfusion is reduced because of the necessity of CCA or ICA occlusion. Difficulties in interpreting the results of studies using these models, which may differ from one laboratory to another, may arise from this methodological difference.
Hypothalamic damage following insertion of a filament suture into the ICA to occlude the MCA has been documented. 4, 8, 40 The hypothalamus is perfused by the ACA, ICA, and PCoA. 34 Because the suture head potentially occludes the ACA and ICA, rather than the MCA alone, the risk of hypothalamic injury may be relatively high. In the rat the hypothalamic artery and the anterior choroidal artery arise from the distal ICA proximal to the MCA bifurcation in the rat. These arteries are thought to be responsible for hyperthermia due to damage in the medial hypothalamus. 12 Subarachnoid hemorrhage and insufficient MCAO are more common in intraluminal suture stroke models. Inadvertent premature reperfusion contributes to interanimal variability. 33 The potential complications described earlier in intraluminal suture stroke models are based on experience with the rat. The same complications could occur in mice because of the structural similarities in cerebral vasculature between mice and rats.
Apart from these technical complications, the major drawback of this model is the high incidence of mortality. In one study a 60-minute intraluminal suture occlusion caused more than an 80% mortality rate in C57Black6 mice. 20 According to the original work by Koizumi and colleagues 21 the mortality rate in a permanent ischemia group was 100%, and all animals died within 32 hours after onset of ischemia. The fact that infarct volumes were assessed at 24 hours following ischemia in the majority of study animals suggests that a survival experiment in which intraluminal suture occlusion is used in mice might also be impossible. Animals survived 14 days after surgery was performed to produce permanent MCAO, but the survival rate was unclear. 18 Data on infarct sizes at 21 days following MCAO are available from another study. 5 The measured infarcts were smaller in volume than ours and, therefore, it is conceivable that in that study the MCA was occluded at a more distal location. Distal MCAO produces limited and inconsistent le- sions in the cortex distal to the occlusion in rats because blood is diverted by PCA-feeding collateral vessels to the ischemic parietal cortex during distal MCAO. 32 In fact, the SD exceeded 50% of the mean infarct volume. 5 Distal MCAO involving mice 1, 38 potentially has the same problem. In our model, 70 to 80% of animals that suffered from large infarcts survived until 7 days after proximal MCAO. The differences in the infarct sizes among the three groups in Experiment 1 (calculated using the Leach formula) were also similar to the differences encountered in Experiment 2. The fact that the SD was within 35% of the mean infarct volume in both Experiments 1 and 2 indicates the consistent reproducibility of our model. The proximal MCAO model is preferable to the distal MCAO model for the assessment of therapeutic agents for stroke in the rat. 31 The difference in the CBF pattern between the intraluminal suture occlusion model and our model is not caused by surgical technique, but possibly by the shutdown and recirculation of collateral flow via the ACA and PCA. The patency of the PCoA did not affect infarct size in our model, although a trend toward decreased infarct size was determined 7 days after onset of permanent MCAO (r = 0.39). When the PCoA is absent or poorly developed, the PCA territory undergoes ischemia during insertion of the suture occluder into the ACA. 20 The exact mechanism as to why the difference in CBF pattern is 20% in permanent MCAO and 30% in transient MCAO during ischemia remains unknown. Parasympathetic and sensory axons, which contain potent vasodilation neurotransmitters and neuromodulators, are located within the vessel adventitia. 26 Electrocauterization of the MCA to produce permanent occlusion could cause the severe reduction in CBF because autonomic nerves innervating the MCA are damaged. 16 It is conceivable that electrocauterization causes more severe damage to these autonomic nerve fibers than clipping.
Three models-including intraluminal suture, 10,14 thromboembolic occlusion, 11, 17 and surgical MCAO-are now available to produce focal cerebral ischemia in mice. The potential complications described earlier should be considered for the former two models.
Direct surgery is also associated with potential problems. First, exposure of the brain to air during the craniectomy may alter intracranial pressure and blood-brain barrier permeability. 6, 15 Second, clipping or cauterizing the proximal MCA may cause damage to the autonomic nerves around the MCA and autoregulation of CBF may be lost. 16 Finally, this method requires surgical skill with an operative microscope. 37 Nonetheless, even if these disadvantages are taken into account, this model provides not only remarkable consistency in infarct size, but also better survival for mice with focal cerebral ischemia. A direct comparison of the three methods of occlusion, undertaken using blood flow analysis, will be needed in future studies.
Conclusions
Surgically induced proximal MCAO in C57Black6 mice provides not only a robust infarct size (which is not affected by the patency of the PCoA), but also a better survival rate. This model will contribute to research on chronic neurological conditions and processes in mice (such as neuronal regeneration and functional recovery following ischemic injury) and resolve the discrepancy between findings in clinical trials and preclinical studies involving mice.
